z-logo
open-access-imgOpen Access
SYNTHESIS AND ANTIOXIDANT EVALUATION OF 3-BROMO-FLAVONE
Author(s) -
Ayu Masyita,
Risfah Yulianty,
Yusnita Rifai
Publication year - 2019
Publication title -
international journal of applied pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.238
H-Index - 15
ISSN - 0975-7058
DOI - 10.22159/ijap.2019.v11s5.t1012
Subject(s) - chemistry , chloroform , chalcone , melting point , derivative (finance) , nuclear chemistry , ethanol , antioxidant , hexane , fourier transform infrared spectroscopy , high performance liquid chromatography , chromatography , medicinal chemistry , organic chemistry , physics , quantum mechanics , financial economics , economics
Objective: The objective of the study was to obtain a flavone derivative compound through N-bromosuccinimide (NBS) reducing the reaction. Theantioxidant activity of the synthetic compound was then assayed by the 2,2-diphenyl-1-picrylhydrazyl method.Methods: Chalcone (3 mmol) as intermediate precursor was suspended with dimethyl sulfoxide and reacted with NBS (3 mmol), stirred at roomtemperature for 25 min and diluted in cold water. The synthesis of flavone derivatives resulted in yellow crystalline powder, freely soluble in methanoland ethanol, renamed 60% with a melting point of 87.7°C. Detection by thin-layer chromatography using hexane:chloroform (2:1) showed single spotwith Rf = 0.38 which is different from the Rf value of the starting compound (chalcone, 0.66 and 0.78).Results: The results of the characterization of the synthesized compound using ultraviolet-visible and Fourier transform-infared showed the groupcharacteristic containing C=C (1604.77 and 1639.49 cm-1), C=O (1681.93 cm-1), C-O-C (1242.16 cm-1), Ar-H (3032.1 and 3062.96 cm-1), and C-Br(663.51 cm-1) at maximum absorption of wavelength 253 nm.Conclusion: The synthesis of flavone using NBS resulted in 3-bromo-flavone with a weak antioxidant activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here